Subscribe

Craneware plc (CRW.L)

GBp1,222.00 +36.00 (+3.04%)
GB LSE Healthcare Medical - Healthcare Information Services
Address 1 Tanfield EH3 5DA
Edinburgh, GB
CEO Keith Neilson
Website public.craneware.com
IPO 2007-09-13
ISIN GB00B2425G68

Explore sections of this company profile

Also trades on London Stock Exchange · CRW.L (GBp) Other OTC · CRWRF (USD)
Description

Craneware plc, with its associated entities, is dedicated to creating, distributing, and maintaining cutting-edge software applications tailored for the U.S. healthcare industry. Its extensive suite of products is designed to streamline and improve a wide array of operational functions for healthcare organizations. Among its flagship offerings is the Chargemaster Toolkit, an automated, cloud-hosted platform for charge master administration, crucial for enabling providers to achieve optimal and legitimate revenue reimbursement. Trisus Supply facilitates the identification and resolution of data inconsistencies between disparate systems. The Physician Revenue Toolkit, a Software-as-a-Service (SaaS) solution, empowers the oversight of physician group performance indicators, billing rates, procedural codes, relative value units, and fee schedules. Complementing these are Reference Plus, another SaaS tool for comprehensive chargemaster analytics, and Pharmacy ChargeLink, engineered to bolster charge capture, pricing strategies, and cost control within pharmacy operations. Furthermore, the company offers integration software that autonomously uploads chargemaster modifications to patient billing systems, thereby ensuring billing precision. The Trisus Pricing Analyzer, a SaaS application, streamlines the pricing model development process. Extending its capabilities, Craneware delivers tools for regulatory adherence and financial oversight: InSight Medical Necessity, a SaaS solution for validating the medical necessity required by U.S. payers and for creating advance beneficiary notices; Trisus Claims Informatics, a program that automates the review of claims and coding; and InSight Audit, a browser-based audit management application for healthcare entities to handle governmental and commercial examinations. Additionally, the firm presents Trisus Healthcare Intelligence, a platform for cost analysis and resource optimization; solutions for pricing transparency; and InSight Denials, which facilitates the analysis, tracking, trending, and reporting of denial data, further supported by appeals management services. Beyond its software offerings, Craneware provides comprehensive client success management, specialized consulting, and an array of professional services. The organization also oversees its own sales, marketing efforts, and continuous product and software innovation. Founded in 1999, Craneware plc has its corporate headquarters situated in Edinburgh, United Kingdom.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
GBp1,222.00 +36.00 (+3.04%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
196.9K
Beta
-0.15
Float Shares
25.09M
Free Float %
73.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+3.01% +0.27% -1.31% -0.73% -31.01% -22.07% -25.17% +13.94% -34.61% +89.18% +962.90%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
1,222.00
DCF (Unlevered) 10,967.28 +797.5%
DCF (Levered) 21,481.21 +1,657.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 5 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
4.14
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Healthcare Information Services: +14.2%
    +8.7% Q4'25: +16.5% (vs Q4'23)
  • ✓
    EPS growth Medical - Healthcare Information Services: +43.1%
    +66.7% ★ Q4'25: +133.3% (vs Q4'23)
  • ✓
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +16.4% Q4'25: +6.8% (vs Q4'23)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    +12.3% ★ Q4'25: +13.5% (vs Q4'23)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    +6.6% ★ Q4'25: +13.7% (vs Q4'23)
  • ✗
    Share dilution Medical - Healthcare Information Services: -0.1%
    +0.9% Q4'25: +1.4% (vs Q4'23)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    0.82× Q4'25: 0.21× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.17) × ERP
WACC = 96% × Ke + 4% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 10,967.28 Current price: 1,222.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Jun 2008
actual 		Jun 2009
actual 		Jun 2010
actual 		Jun 2011
actual 		Jun 2012
actual 		Jun 2013
actual 		Jun 2014
actual 		Jun 2015
actual 		Jun 2016
actual 		Jun 2017
actual 		Jun 2018
actual 		Jun 2019
actual 		Jun 2020
actual 		Jun 2021
actual 		Jun 2022
actual 		Jun 2023
actual 		Jun 2024
actual 		Jun 2025
actual 		Jun 2026
6 Rev. Ana.
5 EPS Ana. 		Jun 2027
6 Rev. Ana.
5 EPS Ana. 		Jun 2028
6 Rev. Ana.
4 EPS Ana.
Revenue
18.68M
est: 37.54M (-50.2%)
22.99M
est: 38.68M (-40.6%)
28.40M
est: 43.62M (-34.9%)
38.12M
est: 61.71M (-38.2%)
41.07M
est: 64.83M (-36.7%)
41.45M
est: 64.40M (-35.6%)
42.57M
est: 76.82M (-44.6%)
44.82M
est: 45.43M (-1.3%)
49.85M
est: 49.63M (+0.4%)
57.80M
est: 57.74M (+0.1%)
67.07M
est: 66.66M (+0.6%)
71.40M
est: 70.85M (+0.8%)
71.49M
est: 71.94M (-0.6%)
75.58M
est: 75.27M (+0.4%)
165.54M
est: 164.89M (+0.4%)
174.02M
est: 173.17M (+0.5%)
189.27M
est: 186.88M (+1.3%)
205.66M
est: 205.49M (+0.1%)
230.65M
230.06M – 231.31M
+12.2% YoY
252.86M
249.61M – 255.04M
+9.6% YoY
275.02M
272.84M – 276.64M
+8.8% YoY
EBITDA
3.93M
est: 9.79M (-59.8%)
5.78M
est: 10.43M (-44.6%)
7.49M
est: 12.50M (-40.1%)
9.98M
est: 16.90M (-41.0%)
13.80M
est: 16.24M (-15.0%)
11.55M
est: 20.07M (-42.4%)
12.18M
est: 22.58M (-46.1%)
13.37M
est: 21.32M (-37.3%)
15.18M
est: 20.40M (-25.6%)
17.31M
est: 24.51M (-29.4%)
19.50M
est: 27.76M (-29.7%)
21.86M
est: 28.16M (-22.4%)
23.87M
est: 27.71M (-13.8%)
18.48M
est: 34.63M (-46.6%)
47.54M
est: 32.74M (+45.2%)
51.60M
est: 34.84M (+48.1%)
54.26M
est: 48.69M (+11.4%)
38.80M
est: 53.58M (-27.6%)
60.14M
59.98M – 60.31M
+12.2% YoY
65.93M
65.08M – 66.50M
+9.6% YoY
71.71M
71.13M – 72.13M
+8.8% YoY
EBIT
3.63M
est: 4.73M (-23.3%)
5.40M
est: 7.32M (-26.3%)
7.05M
est: 9.88M (-28.6%)
9.11M
est: 15.10M (-39.7%)
10.12M
est: 14.42M (-29.8%)
10.60M
est: 17.21M (-38.4%)
11.27M
est: 19.14M (-41.1%)
12.57M
est: 18.39M (-31.7%)
14.41M
est: 18.01M (-20.0%)
16.50M
est: 20.79M (-20.6%)
18.59M
est: 25.31M (-26.5%)
18.32M
est: 25.15M (-27.2%)
19.21M
est: 22.50M (-14.6%)
13.24M
est: 27.64M (-52.1%)
18.13M
est: 26.13M (-30.6%)
19.44M
est: 27.81M (-30.1%)
20.88M
est: 29.67M (-29.6%)
25.35M
est: 25.89M (-2.1%)
29.06M
28.99M – 29.15M
+12.2% YoY
31.86M
31.45M – 32.14M
+9.6% YoY
34.66M
34.38M – 34.86M
+8.8% YoY
Net Income
3.29M
est: 12.67M (-74.0%)
4.45M
est: 6.73M (-33.9%)
5.53M
est: 8.21M (-32.7%)
6.02M
est: 11.83M (-49.2%)
8.89M
est: 10.15M (-12.4%)
8.30M
est: 13.78M (-39.8%)
8.61M
est: 15.13M (-43.1%)
9.39M
est: 14.11M (-33.5%)
10.58M
est: 13.62M (-22.4%)
13.53M
est: 15.92M (-15.0%)
15.80M
est: 20.59M (-23.3%)
14.99M
est: 21.26M (-29.5%)
16.84M
est: 18.73M (-10.1%)
12.91M
est: 24.23M (-46.7%)
9.41M
est: 22.91M (-58.9%)
9.23M
est: 9.23M (+0.0%)
11.70M
est: 32.77M (-64.3%)
19.66M
est: 37.86M (-48.1%)
44.05M
42.24M – 45.86M
+16.3% YoY
49.47M
47.02M – 51.92M
+12.3% YoY
54.16M
47.35M – 60.97M
+9.5% YoY
SGA
2.32M
est: 20.01M (-88.4%)
2.66M
est: 22.85M (-88.4%)
3.31M
est: 23.76M (-86.1%)
4.14M
est: 31.17M (-86.7%)
3.81M
est: 31.07M (-87.7%)
12.68M
est: 30.92M (-59.0%)
13.08M
est: 36.76M (-64.4%)
13.15M
est: 33.99M (-61.3%)
13.97M
est: 31.00M (-54.9%)
16.54M
est: 35.39M (-53.3%)
16.99M
est: 41.88M (-59.4%)
18.45M
est: 39.88M (-53.7%)
17.19M
est: 42.28M (-59.4%)
15.92M
est: 44.37M (-64.1%)
35.65M
est: 41.95M (-15.0%)
129.30M
est: 44.64M (+189.6%)
141.39M
est: 99.52M (+42.1%)
153.98M
est: 109.52M (+40.6%)
122.93M
122.61M – 123.28M
+12.2% YoY
134.76M
133.03M – 135.93M
+9.6% YoY
146.58M
145.41M – 147.44M
+8.8% YoY
EPS
0.14
est: 0.36 (-60.7%)
0.18
est: 0.24 (-25.4%)
0.22
est: 0.29 (-24.6%)
0.23
est: 0.43 (-46.4%)
0.33
est: 0.44 (-24.8%)
0.31
est: 0.47 (-33.7%)
0.32
est: 0.57 (-43.7%)
0.50
est: 0.35 (+41.7%)
0.39
est: 0.41 (-3.7%)
0.50
est: 0.47 (+7.5%)
0.59
est: 0.55 (+7.7%)
0.56
est: 0.66 (-15.3%)
0.63
est: 0.62 (+1.0%)
0.48
est: 0.66 (-27.8%)
0.27
est: 0.85 (-68.2%)
0.26
est: 0.83 (-68.7%)
0.33
est: 0.92 (-64.1%)
0.56
est: 1.07 (-47.5%)
1.24
1.19 – 1.29
+16.6% YoY
1.38
1.32 – 1.46
+11.2% YoY
1.51
1.33 – 1.71
+9.2% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 B+ 3/5 5/5 3/5 4/5 3/5 1/5 2/5
2026-05-28 B+ 3/5 5/5 3/5 4/5 3/5 1/5 2/5
2026-05-27 B+ 3/5 5/5 3/5 4/5 3/5 1/5 2/5
2026-05-26 B+ 3/5 5/5 3/5 4/5 3/5 1/5 2/5
2026-05-22 B+ 3/5 5/5 3/5 4/5 3/5 1/5 2/5
2026-05-21 B+ 3/5 5/5 3/5 4/5 3/5 1/5 2/5
2026-05-20 B+ 3/5 5/5 3/5 4/5 3/5 1/5 2/5
2026-05-19 B+ 3/5 5/5 4/5 4/5 3/5 1/5 2/5
2026-05-18 B+ 3/5 5/5 4/5 4/5 3/5 1/5 2/5
2026-05-15 B+ 3/5 5/5 3/5 4/5 3/5 1/5 3/5
2026-05-14 B+ 3/5 5/5 3/5 4/5 3/5 1/5 3/5
2026-05-13 B+ 3/5 5/5 3/5 4/5 3/5 1/5 3/5
2026-05-12 B+ 3/5 5/5 3/5 4/5 3/5 1/5 3/5
2026-05-11 B+ 3/5 5/5 3/5 4/5 3/5 1/5 3/5
2026-05-08 A- 4/5 5/5 3/5 4/5 3/5 2/5 3/5
2026-05-07 A- 4/5 5/5 3/5 4/5 3/5 2/5 3/5
2026-05-06 A- 4/5 5/5 3/5 4/5 3/5 2/5 3/5
2026-05-05 A- 4/5 5/5 3/5 4/5 3/5 2/5 3/5
2026-05-01 B+ 3/5 5/5 3/5 4/5 2/5 2/5 3/5
2026-04-30 B+ 3/5 5/5 3/5 4/5 2/5 2/5 3/5
2026-04-29 B+ 3/5 5/5 3/5 4/5 2/5 2/5 3/5
2026-04-28 B+ 3/5 5/5 3/5 4/5 2/5 2/5 3/5
2026-04-27 B+ 3/5 5/5 3/5 4/5 2/5 2/5 3/5
2026-04-24 A- 4/5 5/5 3/5 5/5 2/5 2/5 3/5
2026-04-23 B+ 3/5 5/5 3/5 5/5 2/5 1/5 3/5
2026-04-22 B+ 3/5 5/5 3/5 5/5 2/5 1/5 3/5
2026-04-21 B+ 3/5 5/5 3/5 5/5 2/5 1/5 3/5
2026-04-20 B+ 3/5 5/5 3/5 5/5 2/5 1/5 3/5
2026-04-17 B+ 3/5 5/5 3/5 5/5 2/5 1/5 3/5
2026-04-16 B+ 3/5 5/5 3/5 5/5 2/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
80.79M
OE per share TTM
2.28
Owner's Yield
15.31%
Maintenance CapEx ratio
3.53%
Maint CapEx / Avg PPE
4.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 34 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Amundi Prime UK Mid & Small Cap UCITS ETF DR - GBP (D) PRUK.L 0.18% 751.7K 0.05%
2 WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L 0.11% 99.7K 0.38%
3 WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE 0.11% 99.7K 0.38%
4 iShares MSCI United Kingdom Small-Cap ETF EWUS 0.09% 37.3K 0.59%
5 iShares MSCI UK Small Cap UCITS ETF CUKS.L 0.09% 116.5K 0.58%
6 WisdomTree Dynamic International SmallCap Equity ETF DDLS 0.04% 173.5K 0.48%
7 WisdomTree International SmallCap Dividend Fund DLS 0.04% 414.1K 0.58%
8 Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L 0.04% 1.21M 0.30%
9 UBS MSCI United Kingdom IMI Socially Responsible UCITS ETF GBP dis UKSR.L 0.03% 326.5K 0.23%
10 Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA 0.03% 101.2K 0.23%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
33.9K
Shares Outstanding
34.24M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Keith Neilson Co-Founder, Chief Executive Officer & Executive Director 603.1K male
Craig Thomas Preston Chief Financial Officer, Company Secretary & Executive Director 474.4K male
Isabel Urquhart Chief People Officer & Director 316.8K female
Ian Armstrong Chief Growth Officer — male
Jill Goldsmith Company Secretary — —
Lidia A. Rodriguez-Hupp Chief Customer Officer — female
Abhilesh Gandhi Group Chief Technology Officer — male
Tara Hanuscak Chief Transformation Officer — female
Derek William Paterson Chief Information Officer — male
Eric Carter Chief Legal Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services